Evofem Biosciences, Inc. provided sales guidance for the third quarter of 2023. For the expects sales to be $5.0 million to $5.2 million for the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 USD | -4.71% | -6.47% | -79.69% |
1st Jan change | Capi. | |
---|---|---|
-79.69% | 844K | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023